-
-
-
Tadalafil, Eli Lillyâs blockbuster drug for erectile dysfunction, has now been approved to treat signs and symptoms of benign prostatic hyperplasia. Tadalafil is the first drug of its class to be approved for this indication.
-
In a randomized, double-blind, placebo-controlled trial, clonidine and venlafaxine both proved superior to placebo in reducing hot flashes in breast cancer patients. The study was insufficiently powered to prove superiority of one drug over the other. However, venlafaxine produced earlier reductions and it appeared clonidine had more sustained effect (i.e., at 12 weeks of treatment).
-
-
This year will see development of new evidence-based documents for the family planning resource library: the U.S. Selected Practice Recommendations for Contraceptive Use from the Centers for Disease Control & Prevention (CDC) and the newly-updated Title X Program Guidelines, issued by the Office of Family Planning within the Department of Health & Human Services' Office of Population Affairs.
-
The Advisory Committee on Immunization Practices (ACIP) has voted to recommend that males be routinely vaccinated against human papillomavirus (HPV), a move many public health officials seeing as a boost for use of the shot.
-
Get ready to offer women Nexplanon, the latest iteration of the contraceptive implant. The subdermal implant is similar to the Implanon device; however, the applicator has been redesigned to facilitate insertion of the implant in the appropriate subdermal position using one hand.
-
A new point-of-care test for syphilis will provide clinicians another tool in battling increases in the sexually transmitted infection (STI). The new test, Syphilis Health Check (Diagnostics Direct, Stone Harbor, NJ), will no longer require lengthy wait times for results, refrigeration, or the drawing of blood to test for the STI.
-
In October 2011, Ohio became the seventh state to use new authority under the Affordable Care Act (ACA) to extend coverage for family planning services to women and men with incomes well above the state's standard Medicaid income eligibility ceilings.